BioCentury
ARTICLE | Clinical News

Januvia sitagliptin: Phase III data

June 16, 2008 7:00 AM UTC

Two-year data from 402 patients in a Phase III trial showed that 50 mg of Januvia plus 1,000 mg of metformin twice daily reduced HbA1c levels by 1.7% from baseline, while Januvia alone and metformin a...